Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Century Therapeutics (IPSC) R&D In Process (2022)

Historic R&D In Process for Century Therapeutics (IPSC) over the last 1 years, with Q1 2022 value amounting to $10.0 million.

  • Century Therapeutics' R&D In Process changed N/A to $10.0 million in Q1 2022 from the same period last year, while for Dec 2022 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Century Therapeutics reported R&D In Process of $10.0 million as of Q1 2022.
  • In the past 5 years, Century Therapeutics' R&D In Process registered a high of $10.0 million during Q1 2022, and its lowest value of $10.0 million during Q1 2022.